Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Carter, L. Lione, T. Humby, L. Mangiarini, A. Mahal, G. Bates, S. Dunnett, A. Morton, J. Morton (1999)
Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease MutationThe Journal of Neuroscience, 19
J. Vonsattel, R. Myers, Thomas Stevens, R. Ferrante, E. Bird, E. Richardson (1985)
Neuropathological Classification of Huntington's DiseaseJournal of Neuropathology and Experimental Neurology, 44
A. Kazantsev, E. Preisinger, A. Dranovsky, D. Goldgaber, D. Housman (1999)
Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America, 96 20
R. Hughes, Russell Lo, Colleen Davis, A. Strand, Cassandra Neal, J. Olson, S. Fields (2001)
Altered transcription in yeast expressing expanded polyglutamineProceedings of the National Academy of Sciences of the United States of America, 98
Lisa Lione, R. Carter, M. Hunt, G. Bates, A. Morton, S. Dunnett, Lisa Lione, Parke-Davis Neuro (1999)
Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease MutationThe Journal of Neuroscience, 19
A. Strand, J. Olson, C. Kooperberg (2002)
Estimating the statistical significance of gene expression changes observed with oligonucleotide arrays.Human molecular genetics, 11 19
K. Kegel, Manho Kim, E. Sapp, Charmian McIntyre, J. Castaño, N. Aronin, M. Difiglia (2000)
Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and AutophagyThe Journal of Neuroscience, 20
Moon-Gone Kim, Hong Lee, G. Laforet, Charmian McIntyre, E. Martin, Patrick Chang, Tae-Wan Kim, Marie Williams, P. Reddy, D. Tagle, F. Boyce, L. Won, A. Heller, N. Aronin, M. Difiglia (1999)
Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase InhibitionThe Journal of Neuroscience, 19
T. Strong, D. Tagle, J. Valdes, L. Elmer, K. Boehm, M. Swaroop, K. Kaatz, F. Collins, R. Albin (1993)
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissuesNature Genetics, 5
A. McCampbell, A. Taye, L. Whitty, E. Penney, J. Steffan, K. Fischbeck (2001)
Histone deacetylase inhibitors reduce polyglutamine toxicityProceedings of the National Academy of Sciences of the United States of America, 98
M. Turmaine, A. Raza, A. Mahal, L. Mangiarini, G. Bates, S. Davies (2000)
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.Proceedings of the National Academy of Sciences of the United States of America, 97 14
C. Zuccato, A. Ciammola, D. Rigamonti, B. Leavitt, Donato Goffredo, L. Conti, M. MacDonald, R. Friedlander, V. Silani, M. Hayden, T. Timmusk, S. Sipione, E. Cattaneo (2001)
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's DiseaseScience, 293
Joseph Martin (1984)
Huntington's diseaseNeurology, 34
T. Shimohata, O. Onodera, Shoji Tsuji (2001)
Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases.Human cell, 14 1
H. Paulson, K. Fischbeck (1996)
Trinucleotide repeats in neurogenetic disorders.Annual review of neuroscience, 19
Yaohui Chai, S. Koppenhafer, N. Bonini, H. Paulson (1999)
Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine DiseaseThe Journal of Neuroscience, 19
C. Gutekunst, Shihua Li, Hong Yi, James Mulroy, S. Kuemmerle, Randi Jones, David Rye, R. Ferrante, S. Hersch, Xiao-Jiang Li (1999)
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to NeuropathologyThe Journal of Neuroscience, 19
T. Shimohata, T. Nakajima, M. Yamada, C. Uchida, O. Onodera, S. Naruse, Tetsuya Kimura, R. Koide, K. Nozaki, Y. Sano, H. Ishiguro, K. Sakoe, Takayuki Ooshima, A. Sato, T. Ikeuchi, M. Oyake, Toshiya Sato, Yasuyuki Aoyagi, I. Hozumi, T. Nagatsu, Y. Takiyama, M. Nishizawa, J. Goto, I. Kanazawa, I. Davidson, N. Tanese, H. Takahashi, S. Tsuji (2000)
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcriptionNature Genetics, 26
K. Murphy, R. Carter, Lisa Lione, L. Mangiarini, A. Mahal, G. Bates, Stephen Dunnett, A. Morton (2000)
Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease MutationThe Journal of Neuroscience, 20
A. Wyttenbach, Jina Swartz, Hiroko Kita, T. Thykjaer, Jenny Carmichael, Jane Bradley, Rosemary Brown, Michelle Maxwell, A. Schapira, T. Orntoft, Kikuya Kato, D. Rubinsztein (2001)
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.Human molecular genetics, 10 17
D. Bergstrom, Bennett Penn, A. Strand, R. Perry, M. Rudnicki, S. Tapscott (2002)
Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.Molecular cell, 9 3
C. Wellington, L. Ellerby, A. Hackam, R. Margolis, M. Trifiro, R. Singaraja, K. McCutcheon, G. Salvesen, S. Propp, M. Bromm, Kathleen Rowland, Taiqi Zhang, D. Rasper, Sophie Roy, N. Thornberry, L. Pinsky, A. Kakizuka, C. Ross, D. Nicholson, D. Bredesen, M. Hayden (1998)
Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract*The Journal of Biological Chemistry, 273
J. Steffan, A. Kazantsev, O. Spasic-Boskovic, Marilee Greenwald, Ya-zhen Zhu, H. Göhler, E. Wanker, G. Bates, D. Housman, L. Thompson (2000)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.Proceedings of the National Academy of Sciences of the United States of America, 97 12
W. Chun, M. Lesort, J. Tucholski, C. Ross, G. Johnson (2001)
Tissue Transglutaminase Does Not Contribute to the Formation of Mutant Huntingtin AggregatesThe Journal of Cell Biology, 153
A. McCampbell, J. Taylor, A. Taye, Jon Robitschek, Mei Li, Jessica Walcott, D. Merry, Yaohui Chai, H. Paulson, G. Sobue, K. Fischbeck (2000)
CREB-binding protein sequestration by expanded polyglutamine.Human molecular genetics, 9 14
Chin Lin, S. Tallaksen-Greene, W. Chien, J. Cearley, W. Jackson, A. Crouse, S. Ren, Xiao-Jiang Li, R. Albin, P. Detloff (2001)
Neurological abnormalities in a knock-in mouse model of Huntington's disease.Human molecular genetics, 10 2
J. Neurocytol
J. Cha, C. Kosinski, J. Kerner, S. Alsdorf, L. Mangiarini, S. Davies, J. Penney, G. Bates, A. Young (1998)
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.Proceedings of the National Academy of Sciences of the United States of America, 95 11
Edmond Chan, R. Luthi-Carter, A. Strand, S. Solano, S. Hanson, Molly DeJohn, C. Kooperberg, K. Chase, M. Difiglia, A. Young, B. Leavitt, J. Cha, N. Aronin, M. Hayden, J. Olson (2002)
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.Human molecular genetics, 11 17
F. Nucifora, M. Sasaki, M. Peters, H. Huang, J. Cooper, M. Yamada, H. Takahashi, S. Tsuji, J. Troncoso, V. Dawson, T. Dawson, C. Ross (2001)
Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular ToxicityScience, 291
R. Weeks, P. Piccini, A. Harding, D. Brooks (1996)
Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's diseaseAnnals of Neurology, 40
R. Lipshutz, S. Fodor, T. Gingeras, D. Lockhart (1999)
High density synthetic oligonucleotide arraysNature Genetics, 21 Suppl 1
V. Ona, Mingwei Li, J. Vonsattel, L. Andrews, Sohail Khan, W. Chung, A. Frey, A. Menon, Xiao-Jiang Li, P. Stieg, Junying Yuan, J. Penney, A. Young, J. Cha, R. Friedlander (1999)
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's diseaseNature, 399
S. Davies, M. Turmaine, Barbara Cozens, M. Difiglia, A. Sharp, C. Ross, E. Scherzinger, E. Wanker, L. Mangiarini, G. Bates (1997)
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD MutationCell, 90
A. Young (1995)
Huntington's Disease: Lessons from and for Molecular NeuroscienceThe Neuroscientist, 1
Shihua Li, A. Cheng, Hui Zhou, S. Lam, Manjula Rao, He Li, Xiao-Jiang Li (2002)
Interaction of Huntington Disease Protein with Transcriptional Activator Sp1Molecular and Cellular Biology, 22
J. Fain, N. Mar, C. Meade, A. Reiner, D. Goldowitz (2001)
Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation.Human molecular genetics, 10 2
K. Sathasivam, C. Hobbs, M. Turmaine, L. Mangiarini, A. Mahal, F. Bertaux, E. Wanker, P. Doherty, S. Davies, G. Bates (1999)
Formation of polyglutamine inclusions in non-CNS tissue.Human molecular genetics, 8 5
J. Boutell, P. Thomas, J. Neal, Victoria Weston, J. Duce, P. Harper, A. Jones (1999)
Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin.Human molecular genetics, 8 9
R. Luthi-Carter, A. Strand, S. Hanson, C. Kooperberg, Gabriele Schilling, A. Spada, D. Merry, A. Young, C. Ross, D. Borchelt, J. Olson (2002)
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.Human molecular genetics, 11 17
(1999)
Aberrant interactions of transcriptional repressor Human
C. Iannicola, Sandra Moreno, S. Oliverio, R. Nardacci, A. Ciofi-Luzzatto, M. Piacentini (2000)
Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's DiseaseJournal of Neurochemistry, 75
J. Gusella, M. Macdonald (1995)
Huntington's disease.Seminars in cell biology, 6 1
A. McCampbell, K. Fischbeck (2001)
Polyglutamine and CBP: Fatal attraction?Nature Medicine, 7
M. Hurlbert, Wenbo Zhou, C. Wasmeier, F. Kaddis, J. Hutton, C. Freed (1999)
Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.Diabetes, 48 3
F. Trettel, D. Rigamonti, Paige Hilditch-Maguire, V. Wheeler, A. Sharp, F. Persichetti, E. Cattaneo, M. MacDonald (2000)
Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.Human molecular genetics, 9 19
G. Bates (2001)
Huntington's disease: Exploiting expressionNature, 413
Yun Kim, Y. Yi, E. Sapp, Yumei Wang, B. Cuiffo, K. Kegel, Zheng-Hong Qin, N. Aronin, M. Difiglia (2001)
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysisProceedings of the National Academy of Sciences of the United States of America, 98
J. Cha (2000)
Transcriptional dysregulation in Huntington’s diseaseTrends in Neurosciences, 23
T. Ideker, V. Thorsson, J. Ranish, R. Christmas, J. Buhler, J. Eng, Roger Bumgarner, D. Goodlett, R. Aebersold, L. Hood (2001)
Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.Science, 292 5518
R. Luthi-Carter, A. Strand, N. Peters, S. Solano, Z. Hollingsworth, A. Menon, A. Frey, Boris Spektor, E. Penney, Gabriele Schilling, C. Ross, D. Borchelt, S. Tapscott, A. Young, J. Cha, James Olson (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.Human molecular genetics, 9 9
M. Glass, M. Dragunow, R. Faull (2000)
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's diseaseNeuroscience, 97
G. Landwehrmeyer, S. McNeil, L. Dure, P. Ge, H. Aizawa, Qin Huang, C. Ambrose, M. Duyao, E. Bird, E. Bonilla, M. Young, Alejandro Avila‐Gonzales, N. Wexler, M. Difiglia, J. Gusella, M. MacDonald, J. Penney, A. Young, J. Vonsattel (1995)
Huntington's disease gene: Regional and cellular expression in brain of normal and affected individualsAnnals of Neurology, 37
J. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, B. Apostol, A. Kazantsev, E. Schmidt, Ya-zhen Zhu, Marilee Greenwald, R. Kurokawa, D. Housman, G. Jackson, J. Marsh, L. Thompson (2001)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in DrosophilaNature, 413
A. Morton, M. Lagan, J. Skepper, S. Dunnett (2000)
Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutationJournal of Neurocytology, 29
Å. Petersén, K. Mani, P. Brundin (1999)
Recent Advances on the Pathogenesis of Huntington's DiseaseExperimental Neurology, 157
L. Mende-Mueller, T. Toneff, Shin‐Rong Hwang, M. Chesselet, V. Hook (2001)
Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease StriatumThe Journal of Neuroscience, 21
E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G. Bates, S. Davies, H. Lehrach, E. Wanker (1997)
Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In VivoCell, 90
M. MacDonald, C. Ambrose, M. Duyao, R. Myers, Carol Lin, L. Srinidhi, G. Barnes, Sherryl Taylor, M. James, Nicolet Groot, Heather MacFarlane, B. Jenkins, M. Anderson, N. Wexler, J. Gusella, G. Bates, S. Baxendale, H. Hummerich, S. Kirby, M. North, S. Youngman, R. Mott, G. Zehetner, Z. Sedlacek, A. Poustka, A. Frischauf, H. Lehrach, A. Buckler, D. Church, L. Doucette-Stamm, M. O’Donovan, Laura Riba-Ramírez, Manish Shah, V. Stanton, S. Strobel, K. Draths, Jennifer Wales, P. Dervan, D. Housman, M. Altherr, R. Shiang, L. Thompson, T. Fielder, J. Wasmuth, D. Tagle, J. Valdes, Lon Elmer, M. Allard, L. Castilla, M. Swaroop, K. Blanchard, F. Collins, R. Snell, T. Holloway, Kathleen Gillespie, N. Datson, D. Shaw, P. Harper (1993)
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 72
L. Mangiarini, K. Sathasivam, M. Seller, Barbara Cozens, Alex Harper, C. Hetherington, Martin Lawton, Y. Trottier, H. Lehrach, S. Davies, G. Bates (1996)
Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 87
C. Ross, J. Wood, G. Schilling, M. Peters, F. Nucifora, J. Cooper, A. Sharp, R. Margolis, D. Borchelt (1999)
Polyglutamine pathogenesis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 354 1386
A. Dunah, Hyunkyung Jeong, A. Griffin, Yong-Man Kim, D. Standaert, S. Hersch, M. Mouradian, A. Young, N. Tanese, D. Krainc (2002)
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's DiseaseScience, 296
A. Sharp, S. Loev, Gabriele Schilling, Shihua Li, Xiao-Jiang Li, J. Bao, M. Wagster, J. Kotzuk, J. Steiner, A. Lo, J. Hedreen, S. Sisodia, S. Snyder, T. Dawson, D. Ryugo, C. Ross (1995)
Widespread expression of Huntington's disease gene (IT15) protein productNeuron, 14
Previous analyses of gene expression in a mouse model of Huntington's disease (R6/2) indicated that an N-terminal fragment of mutant huntingtin causes downregulation of striatal signaling genes and particularly those normally induced by cAMP and retinoic acid. The present study expands the regional and temporal scope of this previous work by assessing whether similar changes occur in other brain regions affected in Huntington's disease and other polyglutamine diseases and by discerning whether gene expression changes precede the appearance of disease signs. Oligonucleotide microarrays were employed to survey the expression of ∼11 000 mRNAs in the cerebral cortex, cerebellum and striatum of symptomatic R6/2 mice. The number and nature of gene expression changes were similar among these three regions, influenced as expected by regional differences in baseline gene expression. Time-course studies revealed that mRNA changes could only reliably be detected after 4 weeks of age, coincident with development of early pathologic and behavioral changes in these animals. In addition, we discovered that skeletal muscle is also a target of polyglutamine-related perturbations in gene expression, showing changes in mRNAs that are dysregulated in brain and also muscle-specific mRNAs. The complete dataset is available at www.neumetrix.info. « Previous | Next Article » Table of Contents This Article Hum. Mol. Genet. (2002) 11 (17): 1911-1926. doi: 10.1093/hmg/11.17.1911 » Abstract Free Full Text (HTML) Free Full Text (PDF) Free Classifications SPECIAL SERIES: MICROARRAY REPORTS Services Article metrics Alert me when cited Alert me if corrected Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by Luthi-Carter, R. Articles by Olson, J. M. Search for related content PubMed PubMed citation Articles by Luthi-Carter, R. Articles by Hanson, S. A. Articles by Strand, A. D. Articles by Bergstrom, D. A. Articles by Chun, W. Articles by Peters, N. L. Articles by Woods, A. M. Articles by Chan, E. Y. Articles by Kooperberg, C. Articles by Krainc, D. Articles by Young, A. B. Articles by Tapscott, S. J. Articles by Olson, J. M. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue November 15, 2015 24 (22) Alert me to new issues The Journal About this journal Rights & Permissions Dispatch date of the next issue This journal is a member of the Committee on Publication Ethics (COPE) We are mobile – find out more Journals Career Network Impact factor: 6.393 5-Yr impact factor: 6.850 Executive Editors Professor Kay Davies Professor Anthony Wynshaw-Boris Professor Joel Hirschhorn Dr Jeffrey Barrett View full editorial board For Authors Instructions to authors Online submission Submit Now! Self-archiving policy Open access options for authors - visit Oxford Open This journal enables compliance with the NIH Public Access Policy Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed Corporate Services Advertising sales Reprints Supplements var taxonomies = ("SCI01140"); Most Most Read Genetics of obesity and the prediction of risk for health Non-coding RNA Telomerase and cancer Ion channel diseases Down syndrome--recent progress and future prospects » View all Most Read articles Most Cited The DNA methyltransferases of mammals Nonsense-Mediated mRNA Decay in Health and Disease Mutation of human short tandem repeats Prediction of deleterious human alleles Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1460-2083 - Print ISSN 0964-6906 Copyright © 2015 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {}
Human Molecular Genetics – Oxford University Press
Published: Aug 15, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.